Nurasyl Lifesciences Private Limited, a active private limited company, was established on 27 September 2019 in Bharuch, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909GJ2019PTC110092. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Maulikkumar Jaysukhbhai Sudani (Director), Jignasu Jaysukhbhai Sudani (Director), Tejas Ramesh Zaveri (Director). Past directors included Nirav Vikram Maniar, Tejas Ramesh Zaveri, Jignasu Jaysukhbhai Sudani. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 1508, G.I.D.C, Ankleshwar,, Bharuch, Gujarat, 393002.
U51909GJ2019PTC110092
110092
27 September 2019
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nurasyl Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maulikkumar Jaysukhbhai Sudani | Director | 27 Sep 2019 | Current |
| Jignasu Jaysukhbhai Sudani | Director | 27 Sep 2019 | Current |
| Tejas Ramesh Zaveri | Director | 01 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nurasyl Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 106.22% increase in profit. The company's net worth moved up by a moderate rise of 6.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Nurasyl Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nurasyl Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nurasyl Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nurasyl Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nurasyl Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Nurasyl Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity Tejas Ramesh Zaveri was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
Maulikkumar Jaysukhbhai Sudani was appointed as a Director was appointed as a Director on 27 Sep 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Jignasu Jaysukhbhai Sudani was appointed as a Director was appointed as a Director on 27 Sep 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Progress on Nurasyl Lifesciences Private Limited was registered on 27 Sep 2019 with Roc Ahmedabad & aged 6 years 2 months as per MCA records. was documented.
The CIN of Nurasyl Lifesciences Private Limited is U51909GJ2019PTC110092.
Nurasyl Lifesciences Private Limited is headquartered at Plot No. 1508, G.I.D.C, Ankleshwar,, Bharuch, Gujarat, 393002.
Nurasyl Lifesciences Private Limited was incorporated on 27 September 2019.
The current directors of Nurasyl Lifesciences Private Limited are
The primary industry of Nurasyl Lifesciences Private Limited is Trade.
Nurasyl Lifesciences Private Limited is unlisted.
The authorized capital of Nurasyl Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX